ID   GLSL_HUMAN              Reviewed;         602 AA.
AC   Q9UI32; B7Z8Q9; Q8IX91; Q9NYY2; Q9UI31;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 2.
DT   10-MAY-2017, entry version 158.
DE   RecName: Full=Glutaminase liver isoform, mitochondrial;
DE            Short=GLS;
DE            EC=3.5.1.2;
DE   AltName: Full=L-glutaminase;
DE   AltName: Full=L-glutamine amidohydrolase;
DE   Flags: Precursor;
GN   Name=GLS2; Synonyms=GA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain, and Mammary cancer;
RX   PubMed=10620514; DOI=10.1042/bj3450365;
RA   Gomez-Fabre P.M., Aledo J.C., del Castillo-Olivares A., Alonso F.J.,
RA   Nunez de Castro I., Campos J.A., Marquez J.;
RT   "Molecular cloning, sequencing and expression studies of the human
RT   breast cancer cell glutaminase.";
RL   Biochem. J. 345:365-375(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain, and Mammary cancer;
RX   PubMed=12444921; DOI=10.1042/BJ20021445;
RA   Perez-Gomez C., Mates J.M., Gomez-Fabre P.M.,
RA   del Castillo-Olivares A., Alonso F.J., Marquez J.;
RT   "Genomic organization and transcriptional analysis of the human l-
RT   glutaminase gene.";
RL   Biochem. J. 370:771-784(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT PRO-581.
RC   TISSUE=Brain;
RA   Chavez R.A., Wang C., Cong R., Hawkinson J.E., Forsayeth J.R.;
RT   "Identification and expression of human renal and hepatic glutaminase
RT   isoforms.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INTERACTION WITH SNTA1 AND TAX1BP3.
RX   PubMed=11163757; DOI=10.1016/S0014-5793(00)02373-5;
RA   Olalla L., Aledo J.C., Bannenberg G., Marquez J.;
RT   "The C-terminus of human glutaminase L mediates association with PDZ
RT   domain-containing proteins.";
RL   FEBS Lett. 488:116-122(2001).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=20378837; DOI=10.1073/pnas.1001006107;
RA   Hu W., Zhang C., Wu R., Sun Y., Levine A., Feng Z.;
RT   "Glutaminase 2, a novel p53 target gene regulating energy metabolism
RT   and antioxidant function.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:7455-7460(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Plays an important role in the regulation of glutamine
CC       catabolism. Promotes mitochondrial respiration and increases ATP
CC       generation in cells by catalyzing the synthesis of glutamate and
CC       alpha-ketoglutarate. Increases cellular anti-oxidant function via
CC       NADH and glutathione production. May play a role in preventing
CC       tumor proliferation. {ECO:0000269|PubMed:20378837}.
CC   -!- CATALYTIC ACTIVITY: L-glutamine + H(2)O = L-glutamate + NH(3).
CC   -!- SUBUNIT: Interacts with the PDZ domain of the syntrophin SNTA1.
CC       Interacts with the PDZ domain of TAX1BP3.
CC       {ECO:0000269|PubMed:11163757}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:20378837}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UI32-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UI32-2; Sequence=VSP_057009, VSP_057010;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver. Expressed in brain
CC       and pancreas. Not observed in heart, placenta, lung, skeletal
CC       muscle and kidney. Expression is significantly reduced in
CC       hepatocellular carcinomas. {ECO:0000269|PubMed:10620514,
CC       ECO:0000269|PubMed:20378837}.
CC   -!- INDUCTION: Up-regulated by P53 (at protein and mRNA level) under
CC       both stressed and non-stressed conditions.
CC       {ECO:0000269|PubMed:20378837}.
CC   -!- SIMILARITY: Belongs to the glutaminase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF110330; AAF21933.1; -; mRNA.
DR   EMBL; AF110331; AAF21934.1; -; mRNA.
DR   EMBL; AF348119; AAO13298.2; -; Genomic_DNA.
DR   EMBL; AF223944; AAF33826.1; -; mRNA.
DR   EMBL; AK303772; BAH14045.1; -; mRNA.
DR   EMBL; AC097104; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW96943.1; -; Genomic_DNA.
DR   CCDS; CCDS8921.1; -. [Q9UI32-1]
DR   RefSeq; NP_001267727.1; NM_001280798.1.
DR   RefSeq; NP_037399.2; NM_013267.3. [Q9UI32-1]
DR   UniGene; Hs.212606; -.
DR   PDB; 4BQM; X-ray; 2.18 A; A/B=154-479.
DR   PDBsum; 4BQM; -.
DR   ProteinModelPortal; Q9UI32; -.
DR   SMR; Q9UI32; -.
DR   BioGrid; 118044; 3.
DR   IntAct; Q9UI32; 2.
DR   MINT; MINT-157952; -.
DR   STRING; 9606.ENSP00000310447; -.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00130; L-Glutamine.
DR   iPTMnet; Q9UI32; -.
DR   PhosphoSitePlus; Q9UI32; -.
DR   BioMuta; GLS2; -.
DR   DMDM; 145559477; -.
DR   EPD; Q9UI32; -.
DR   PaxDb; Q9UI32; -.
DR   PeptideAtlas; Q9UI32; -.
DR   PRIDE; Q9UI32; -.
DR   DNASU; 27165; -.
DR   Ensembl; ENST00000311966; ENSP00000310447; ENSG00000135423. [Q9UI32-1]
DR   Ensembl; ENST00000486896; ENSP00000419661; ENSG00000135423. [Q9UI32-2]
DR   GeneID; 27165; -.
DR   KEGG; hsa:27165; -.
DR   UCSC; uc001slj.5; human. [Q9UI32-1]
DR   CTD; 27165; -.
DR   DisGeNET; 27165; -.
DR   GeneCards; GLS2; -.
DR   HGNC; HGNC:29570; GLS2.
DR   HPA; HPA038608; -.
DR   MIM; 606365; gene.
DR   neXtProt; NX_Q9UI32; -.
DR   OpenTargets; ENSG00000135423; -.
DR   PharmGKB; PA134933506; -.
DR   eggNOG; KOG0506; Eukaryota.
DR   eggNOG; COG2066; LUCA.
DR   GeneTree; ENSGT00390000010463; -.
DR   HOGENOM; HOG000012985; -.
DR   HOVERGEN; HBG005856; -.
DR   InParanoid; Q9UI32; -.
DR   KO; K01425; -.
DR   OMA; CVKPLTY; -.
DR   OrthoDB; EOG091G03YU; -.
DR   PhylomeDB; Q9UI32; -.
DR   TreeFam; TF313359; -.
DR   Reactome; R-HSA-210500; Glutamate Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-70614; Amino acid synthesis and interconversion (transamination).
DR   SABIO-RK; Q9UI32; -.
DR   ChiTaRS; GLS2; human.
DR   GenomeRNAi; 27165; -.
DR   PRO; PR:Q9UI32; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000135423; -.
DR   CleanEx; HS_GLS2; -.
DR   ExpressionAtlas; Q9UI32; baseline and differential.
DR   Genevisible; Q9UI32; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0004359; F:glutaminase activity; IBA:GO_Central.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc.
DR   GO; GO:0006537; P:glutamate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0014047; P:glutamate secretion; TAS:Reactome.
DR   GO; GO:0006543; P:glutamine catabolic process; IBA:GO_Central.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IMP:MGI.
DR   GO; GO:0042981; P:regulation of apoptotic process; IMP:MGI.
DR   Gene3D; 1.25.40.20; -; 1.
DR   HAMAP; MF_00313; Glutaminase; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR012338; Beta-lactam/transpept-like.
DR   InterPro; IPR015868; Glutaminase.
DR   PANTHER; PTHR12544; PTHR12544; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF04960; Glutaminase; 1.
DR   SMART; SM00248; ANK; 2.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF56601; SSF56601; 1.
DR   TIGRFAMs; TIGR03814; Gln_ase; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ANK repeat;
KW   Complete proteome; Hydrolase; Mitochondrion; Polymorphism;
KW   Reference proteome; Repeat; Transit peptide.
FT   TRANSIT       1     14       Mitochondrion. {ECO:0000255}.
FT   CHAIN        15    602       Glutaminase liver isoform, mitochondrial.
FT                                /FTId=PRO_0000011625.
FT   REPEAT      518    551       ANK 1.
FT   REPEAT      552    585       ANK 2.
FT   BINDING     219    219       Substrate. {ECO:0000250}.
FT   BINDING     268    268       Substrate. {ECO:0000250}.
FT   BINDING     314    314       Substrate. {ECO:0000250}.
FT   BINDING     321    321       Substrate. {ECO:0000250}.
FT   BINDING     347    347       Substrate. {ECO:0000250}.
FT   BINDING     399    399       Substrate. {ECO:0000250}.
FT   BINDING     417    417       Substrate; via amide nitrogen.
FT                                {ECO:0000250}.
FT   MOD_RES     253    253       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q571F8}.
FT   MOD_RES     279    279       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q571F8}.
FT   MOD_RES     284    284       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q571F8}.
FT   MOD_RES     329    329       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q571F8}.
FT   VAR_SEQ     136    209       CVSSNIVLLTQAFRKKFVIPDFEEFTGHVDRIFEDVKELTG
FT                                GKVAAYIPQLAKSNPDLWGVSLCTVDGQRHSVG -> HSER
FT                                SLSFLILRSSRAMWIASLRMSKSSLEAKWQPTSLSWPSQTQ
FT                                TCGVSPCALWMVNGTLWATQRSPSACSPV (in isoform
FT                                2). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057009.
FT   VAR_SEQ     210    602       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057010.
FT   VARIANT     581    581       L -> P (in dbSNP:rs2657879).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_031615.
FT   CONFLICT     87     87       I -> T (in Ref. 1; AAF21933).
FT                                {ECO:0000305}.
FT   CONFLICT    140    140       N -> S (in Ref. 1; AAF21933).
FT                                {ECO:0000305}.
FT   CONFLICT    257    257       N -> D (in Ref. 1; AAF21933).
FT                                {ECO:0000305}.
FT   CONFLICT    328    329       LK -> HE (in Ref. 1; AAF21933).
FT                                {ECO:0000305}.
FT   CONFLICT    560    560       A -> V (in Ref. 3; AAF33826).
FT                                {ECO:0000305}.
FT   HELIX       157    171       {ECO:0000244|PDB:4BQM}.
FT   STRAND      177    179       {ECO:0000244|PDB:4BQM}.
FT   HELIX       187    189       {ECO:0000244|PDB:4BQM}.
FT   STRAND      195    200       {ECO:0000244|PDB:4BQM}.
FT   STRAND      205    210       {ECO:0000244|PDB:4BQM}.
FT   HELIX       218    221       {ECO:0000244|PDB:4BQM}.
FT   HELIX       222    233       {ECO:0000244|PDB:4BQM}.
FT   HELIX       235    238       {ECO:0000244|PDB:4BQM}.
FT   TURN        239    241       {ECO:0000244|PDB:4BQM}.
FT   HELIX       268    277       {ECO:0000244|PDB:4BQM}.
FT   TURN        278    281       {ECO:0000244|PDB:4BQM}.
FT   HELIX       284    298       {ECO:0000244|PDB:4BQM}.
FT   TURN        299    301       {ECO:0000244|PDB:4BQM}.
FT   HELIX       308    317       {ECO:0000244|PDB:4BQM}.
FT   HELIX       319    330       {ECO:0000244|PDB:4BQM}.
FT   HELIX       340    351       {ECO:0000244|PDB:4BQM}.
FT   STRAND      353    355       {ECO:0000244|PDB:4BQM}.
FT   HELIX       357    368       {ECO:0000244|PDB:4BQM}.
FT   TURN        369    371       {ECO:0000244|PDB:4BQM}.
FT   TURN        374    376       {ECO:0000244|PDB:4BQM}.
FT   HELIX       383    396       {ECO:0000244|PDB:4BQM}.
FT   HELIX       399    401       {ECO:0000244|PDB:4BQM}.
FT   HELIX       402    408       {ECO:0000244|PDB:4BQM}.
FT   STRAND      413    415       {ECO:0000244|PDB:4BQM}.
FT   STRAND      419    425       {ECO:0000244|PDB:4BQM}.
FT   TURN        426    428       {ECO:0000244|PDB:4BQM}.
FT   STRAND      429    434       {ECO:0000244|PDB:4BQM}.
FT   STRAND      442    444       {ECO:0000244|PDB:4BQM}.
FT   HELIX       445    458       {ECO:0000244|PDB:4BQM}.
SQ   SEQUENCE   602 AA;  66323 MW;  6D0E1EFF01BC3843 CRC64;
     MRSMKALQKA LSRAGSHCGR GGWGHPSRSP LLGGGVRHHL SEAAAQGRET PHSHQPQHQD
     HDSSESGMLS RLGDLLFYTI AEGQERIPIH KFTTALKATG LQTSDPRLRD CMSEMHRVVQ
     ESSSGGLLDR DLFRKCVSSN IVLLTQAFRK KFVIPDFEEF TGHVDRIFED VKELTGGKVA
     AYIPQLAKSN PDLWGVSLCT VDGQRHSVGH TKIPFCLQSC VKPLTYAISI STLGTDYVHK
     FVGKEPSGLR YNKLSLNEEG IPHNPMVNAG AIVVSSLIKM DCNKAEKFDF VLQYLNKMAG
     NEYMGFSNAT FQSEKETGDR NYAIGYYLKE KKCFPKGVDM MAALDLYFQL CSVEVTCESG
     SVMAATLANG GICPITGESV LSAEAVRNTL SLMHSCGMYD FSGQFAFHVG LPAKSAVSGA
     ILLVVPNVMG MMCLSPPLDK LGNSHRGTSF CQKLVSLFNF HNYDNLRHCA RKLDPRREGA
     EIRNKTVVNL LFAAYSGDVS ALRRFALSAM DMEQKDYDSR TALHVAAAEG HIEVVKFLIE
     ACKVNPFAKD RWGNIPLDDA VQFNHLEVVK LLQDYQDSYT LSETQAEAAA EALSKENLES
     MV
//
